Form 4 for VYGR Voyager Therapeutics, Inc.
Accepted 2023-02-24 00:00:00 ET · period of report 2023-02-23 · accession 0000899243-23-006093 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-24 | 2023-02-23 | VYGR | NEUROCRINE BIOSCIENCES INC | 10% | P - Purchase | $8.88 | +4.40M | 8.58M | +105% | +$39.03M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-23 | P | A | 4,395,588 | $8.88 | 8,575,316 | D | — | — | (F1) The purchase price was determined in accordance with that certain Stock Purchase Agreement dated January 8, 2023, between the reporting person and the issuer. |